
About CRIL
CRIL is a company based in Cambridge (United Kingdom) founded in 2018 by Giulio Cerullo. CRIL has raised $1.7 million across 8 funding rounds from investors including Frontier IP, European Union and Graphene Flagship. The company has 1 employees. CRIL offers products and services including STRALE, CHAMP, and CORAL. CRIL operates in a competitive market with competitors including Oxford Instruments, Leica Microsystems, IBA, Scholar Rock and SpectraWAVE, among others.
- Headquarter Cambridge, United Kingdom
- Employees 1
- Founders Giulio Cerullo
- SectorsHealthcareTechnology
- Emailβ’β’β’β’β’β’β’β’
- Website cambridgeramanimaging.com
- Social LinkedIn Facebook
- Legal Name Cambridge Raman Imaging Ltd
- Date of Incorporation 15 Mar, 2018
- Jurisdiction CAMBRIDGE, CAMBRIDGESHIRE, UNITED KINGDOM
- Total Equity Funding$1.7M (USD)
in 8 rounds
- Latest Funding Round$1.38M (USD), Seed
May 2022
- InvestorsFrontier IP
& 2 more
- Employee Count1
Products & Services of CRIL
CRIL offers a comprehensive portfolio of products and services, including STRALE, CHAMP, and CORAL.
Ultra-fast laser for coherent Raman imaging in tissue analysis.
Advanced tool for high-speed label-free cell diagnostics.
Platform for AI-assisted Raman scattering microscopy applications.
Funding Insights of CRIL
CRIL has successfully raised a total of $1.7M across 8 strategic funding rounds. The most recent funding activity was a Seed round of $1.38 million completed in May 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.7M
- Total Rounds 8
- Last Round Seed β $1.38M
- First Round $151,317
(Feb 2020)
- Investors Count 3
All 8 funding rounds of CRIL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2022 | $1.38M | Seed | β | β | |
| May 2022 | $119,356 | Debt – Conventional | β | β | β |
| Dec 2020 | $829,098 | Grant | β | β | |
| Oct 2020 | – | Grant | β | β | |
| Jul 2020 | $314,100 | Seed | β | β | β |
| Jul 2020 | – | Seed | β | β | β |
| Apr 2020 | – | Grant | β | β | |
| Feb 2020 | $151,317 | Grant | β | β |
3 investors in total: 3 institutional.
Investors in CRIL
CRIL has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Frontier IP, European Union and Graphene Flagship.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Asset management consulting services are provided by Frontier IP. | 2009 | frontierip.co.uk | Edinburgh, United Kingdom | |
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Research and innovation in graphene and 2D materials are facilitated. | – | graphene-flagship.eu | - |
Investor details for CRIL
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CRIL
1 people are tracked at CRIL (1 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
Giulio Cerullo | Co-Founder | Leadership |
Complete people profiles for CRIL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CRIL
3 dated milestones of CRIL across 4 years, from founding to its latest funding, stage changes and deals.
- Founded CRIL is founded.
- Funding First funding round of $151K.
- Funding Latest funding round, Seed, of $1.4M.
Competitors of CRIL
CRIL operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Oxford Instruments, Leica Microsystems, IBA, Scholar Rock and SpectraWAVE, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| oxinst.com | 1959 | Abingdon, United Kingdom | – | 2,027 | Technology tools and systems for molecular scale are developed. | |
| leica-microsystems.com | 1914 | Wetzlar, Germany | – | 67 | Imaging solutions for macro, micro, and nano structures are provided. | |
| iba-worldwide.com | 1986 | – | $27.32M | – | Innovative solutions for cancer treatment and industrial applications are provided by IBA. | |
| scholarrock.com | 2012 | Cambridge, United States | $103.3M | 150 | Antibody-based drugs for primary myopathies are developed and targeted. | |
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| fluxionbio.com | 2005 | San Francisco, United States | $20.85M | – | Microfluidics-based tools for cellular analysis are provided. | |
| metrohm.com | 1943 | Herisau, Switzerland | – | 608 | Instruments for chemical analysis are developed and manufactured. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. | |
| samantree.com | 2014 | Lausanne, Switzerland | $33.78M | – | A surgical digital microscope for tumor resection is developed. | |
| phasefocus.com | 2006 | Sheffield, United Kingdom | $12.08M | 10 | Provider of virtual lens that generates High definition images without high-quality lenses |
Detailed competitors of CRIL
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of CRIL
The website of CRIL (cambridgeramanimaging.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▲ 9.9% vs previous month
Latest news on Cril
Complete news archive for CRIL
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to CRIL
10 companies that operate in the same segment as CRIL (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 190 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.17 M | – | 242 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – | |
Portable MRI systems are manufactured for medical professionals. | 2014 | New York, New York, United States | – | USD 13.56 M | 111 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CRIL
CRIL was founded in 2018 and raised its 1st funding round 2 years after it was founded.
CRIL is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
CRIL is a funded company, having raised a total of $1.7M across 8 funding rounds to date. The company's 1st funding round was a Grant of $151.32K, raised on Feb 2020.
CRIL has 1 employees.
CRIL was founded in 2018 in Cambridge, United Kingdom. Devices incorporating AI for cell analysis and tissue diagnosis are developed by the company within the biotechnology sector. The Coherent Raman Platform serves as a digital imaging tool to assess images used in diagnosis, cellular process evaluation, drug discovery, and therapy monitoring. Operations center on medical imaging applications for research and clinical settings.
CRIL's top competitors include Oxford Instruments, Scholar Rock and Leica Microsystems.
CRIL offers STRALE, CHAMP, and CORAL.
CRIL has 3 investors. Key investors include Frontier IP, European Union, and Graphene Flagship.
CRIL operates through Cambridge Raman Imaging Ltd.
